HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Inhaled drug trial aims to shield cancer patients from dangerous viral pneumonia
Disease control Recruiting nowThis study is testing whether an inhaled experimental drug called PUL-042 can reduce the severity of lung infections in a very vulnerable group: adults with blood cancers or who have received a stem cell transplant. These patients have weakened immune systems and are at high risk…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Pulmotect, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug trial aims to keep deadly leukemia at bay after transplant
Disease control Recruiting nowThis study is testing whether a drug called ivosidenib can help prevent acute myeloid leukemia (AML) from returning after a stem cell transplant. About 75 adults with a specific genetic mutation in their leukemia will receive either the study drug or a placebo for up to two years…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC